首页> 外文会议>1996 Chinese Peptide Symposium July 21-25, 1996, Chengdu, China >Libraries of synthetic glycopeptides in the characterization of hte T cell response to tumor associated mucin antigens
【24h】

Libraries of synthetic glycopeptides in the characterization of hte T cell response to tumor associated mucin antigens

机译:合成糖肽文库用于表征Hte T细胞对肿瘤相关粘蛋白抗原的反应

获取原文
获取原文并翻译 | 示例

摘要

It has been well established that T cell stimulation is mediated by the presentation of peptide antigens by the MHC molecules on the surface of the antigen presenting cells. The peptides are fragments of proteins or even glycoproteins. The design of the binding groove of the MHC molecule is such that it only binds to peptides in their more or less extended coformation by interaction with anchor residues often towards the terminal ends. Carbohydrates and lipids do not interact with the MHC molecules and they belong to the group of T cell independent antigens unable to elicit a T cel response. However, the elution and analysis of peptides bound to the MHC molecules has revealed that glycan residues remaining from glycoprotein degradation could be attached to peptides bound to the MHC molecules [1]. It is therefore important to investigate the immunogenicity of glycopeptides, in particular the changes observed in the mucin glycosylation pattern in the case of e.g. colon cancer cells due to down regulation of enzymes leading to aberrant glycosylation [2]. Nothing is known about the specificity of the T cell response to glycans attached to peptides binding to MHC. The E~k restricted self peptide, VITAFNEGLK, from CBA/J mouse hemoglobin (67-76) is known to bind well MHC class II molecules, but is unable to stimulate the CD4~+ T cells to proliferate [3]. Conversion of such a non-immunogenic peptide into an immunogen by glycosylation would indicate that the T cell specificity was due to direct contact between the glycan and the binding domain of the TCR. Furthermore, by modifying the glycan in this mdoel for T cell-glycan recognition it would be possible to study the detailed molecular interactions betwen the glycan and the TCR, which in turn could lead to knowledge about the requirements for the efficient design of cancer vaccines.
机译:众所周知,T细胞刺激是通过抗原呈递细胞表面上的MHC分子呈递肽抗原来介导的。肽是蛋白质或什至糖蛋白的片段。 MHC分子的结合槽的设计使得它仅通过与锚定残基相互作用而通常或多或少的扩展共形成形式与肽结合而结合至末端。碳水化合物和脂质不与MHC分子相互作用,它们属于无法引起T cel反应的T细胞非依赖性抗原。然而,对与MHC分子结合的肽的洗脱和分析表明,糖蛋白降解残留的聚糖残基可以与与MHC分子结合的肽连接[1]。因此,重要的是研究糖肽的免疫原性,特别是在例如大肠杆菌的情况下在粘蛋白糖基化模式中观察到的变化。结肠癌细胞由于酶的下调导致异常的糖基化[2]。关于附着于结合MHC的肽的聚糖上的T细胞应答的特异性,目前尚无定论。已知来自CBA / J小鼠血红蛋白的Ek限制性自身肽VITAFNEGLK(67-76)可以很好地结合II类MHC分子,但不能刺激CD4 + T细胞增殖[3]。通过糖基化将这种非免疫原性肽转化为免疫原将表明T细胞特异性是由于聚糖与TCR的结合结构域之间的直接接触所致。此外,通过修饰该mdoel中的聚糖以识别T细胞-聚糖,将有可能研究聚糖和TCR之间的详细分子相互作用,进而可以了解有关癌症疫苗有效设计要求的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号